| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An improved strategy to detect the epithelial-mesenchymal transition process in circulating tumor cells in hepatocellular carcinoma patients
|
Liu, Yong-kang
|
|
2016
|
10 |
4 |
p. 640-646
|
artikel
|
| 2 |
Association between hepatitis B virus basal core promoter/precore region mutations and the risk of hepatitis B-related acute-on-chronic liver failure in the Chinese population: an updated meta-analysis
|
Nian, Xueyuan
|
|
2016
|
10 |
4 |
p. 606-615
|
artikel
|
| 3 |
Biliary complications in right lobe living donor liver transplantation
|
Chok, Kenneth S. H.
|
|
2016
|
10 |
4 |
p. 553-558
|
artikel
|
| 4 |
Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis
|
Mohamad, Bashar
|
|
2015
|
10 |
4 |
p. 632-639
|
artikel
|
| 5 |
Difference in clinical presentation, immunology profile and treatment response of type 1 autoimmune hepatitis between United Kingdom and Singapore patients
|
Than, Nwe Ni
|
|
2016
|
10 |
4 |
p. 673-679
|
artikel
|
| 6 |
Examining the clinical course of genotype 1 chronic hepatitis C patients treated with the cosmos regimen: including patients with advanced liver disease and East Asian ancestry
|
Roytman, Marina
|
|
2016
|
10 |
4 |
p. 616-623
|
artikel
|
| 7 |
Examining the clinical course of genotype 1 chronic hepatitis C patients treated with the cosmos regimen: including patients with advanced liver disease and East Asian ancestry
|
Roytman, Marina
|
|
|
10 |
4 |
p. 616-623
|
artikel
|
| 8 |
HBV culture and infectious systems
|
Hayes, C. Nelson
|
|
2016
|
10 |
4 |
p. 559-566
|
artikel
|
| 9 |
Hepatitis B virus receptors and molecular drug targets
|
Verrier, Eloi R.
|
|
2016
|
10 |
4 |
p. 567-573
|
artikel
|
| 10 |
Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan
|
Akuta, Norio
|
|
2016
|
10 |
4 |
p. 647-656
|
artikel
|
| 11 |
iNKT cells in chronic HBV: a balancing act
|
Hofmann, Maike
|
|
2016
|
10 |
4 |
p. 535-537
|
artikel
|
| 12 |
Is response guided therapy dead? Low cure rates in patients with detectable hepatitis C virus at week 4 of treatment
|
Thornton, Karla
|
|
2016
|
10 |
4 |
p. 624-631
|
artikel
|
| 13 |
NAFLD as a risk factor for HCC: new rules of engagement?
|
Masuzaki, Ryota
|
|
2016
|
10 |
4 |
p. 533-534
|
artikel
|
| 14 |
New therapeutic targets in alcoholic hepatitis
|
Arsene, Diana
|
|
2016
|
10 |
4 |
p. 538-552
|
artikel
|
| 15 |
Prevention of hepatitis B virus-associated liver diseases by antiviral therapy
|
Tawada, Akinobu
|
|
2016
|
10 |
4 |
p. 574-593
|
artikel
|
| 16 |
Role of cytokine gene polymorphisms in acute and chronic kidney disease following liver transplantation
|
Kamei, Hideya
|
|
2016
|
10 |
4 |
p. 665-672
|
artikel
|
| 17 |
Selection and outcome of the potential live liver donor
|
Pamecha, Viniyendra
|
|
2016
|
10 |
4 |
p. 657-664
|
artikel
|
| 18 |
The dynamic changes of circulating invariant natural killer T cells during chronic hepatitis B virus infection
|
Li, Man
|
|
2016
|
10 |
4 |
p. 594-601
|
artikel
|
| 19 |
Will a second biopsy sample affect treatment decisions in patients with chronic hepatitis B?
|
Ekiz, Fuat
|
|
2015
|
10 |
4 |
p. 602-605
|
artikel
|
Tijdschrift beschrijving